Peptic Ulcer. Gastroduodenal Ulcer NOS
Conditions
Interventions
Intervention 1: Group I: Quadruple Therapy (OfAB) with low-dose (amoxicillin mg-BD 1000, furazolidone mg-BD 100, omeprazole mg-BD20 Vbysmvt subcitrate mg-BD 240 for 2 weeks). Intervention 2: Group II:
Treatment - Drugs
Group I: Quadruple Therapy (OfAB) with low-dose (amoxicillin mg-BD 1000, furazolidone mg-BD 100, omeprazole mg-BD20 Vbysmvt subcitrate mg-BD 240 for 2 weeks)
Group II: Quadruple therapy (OFAB) high dose (amoxicillin mg-BD 1000, furazolidone mg-BD 200, omeprazole mg-BD20 Vbysmvt subcitrate mg-BD 240 for 2 weeks)
Sponsors
Golestan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: peptic ulcer with endoscopic diagnosis, proof of Helicobacter pylori infection by testing RUT; consenting to the partnership Exclusion criteria: pregnancy, the risk of cancer, liver failure and kidney disease, diabetes mellitus, history of taking NSAIDs; PPI; bismuth; anti- antibiotics during the past 4 weeks, history of smoking and alcohol; history of drug allergy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| H.Pylori eradication. Timepoint: After Intervention. Method of measurement: ELISA Method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Peptic Ulcer cure. Timepoint: after intervention. Method of measurement: by Endoscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Majid Rajabi
Golestan University of Medical Sciences
Outcome results
None listed